Showing results (131-140 of 362) with videos related to

Sort By:
Pageof 37
Coronary Artery Disease|November 24, 1999
Vascular risk factors correlate to the extent as well as the severity of coronary atherosclerosisS H Wilson, D S Celermajer, A Nakagomi, et al.
International Journal of Molecular Sciences|February 21, 2020
High-Density Lipoprotein (HDL) Inhibits Serum Amyloid A (SAA)-Induced Vascular and Renal Dysfunctions in Apolipoprotein E-Deficient MiceXiaoping Cai, Gulfam Ahmad, Farjaneh Hossain, et al.
European Journal of Pediatrics|December 24, 2025
Utility of transcranial Doppler and reversed jugular venous saturations for neuromonitoring in children with acute liver failureRaman Singla, Emma C Alexander, Pervez Khan, et al.
Heart, Lung & Circulation|April 2, 2010
Rheumatic heart disease in indigenous populationsHarvey White, Warren Walsh, Alex Brown, et al.
Heart, Lung & Circulation|April 3, 2010
Improving cardiovascular care for indigenous populationsRichmond Jeremy, Andrew Tonkin, Harvey White, et al.
The Medical Journal of Australia|February 19, 2008
Variations in the application of cardiac care in AustraliaDarren L Walters, Constantine N Aroney, Derek P Chew, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|September 21, 2017
The contribution of the composite of clinical process indicators as a measure of hospital performance in the management of acute coronary syndromes-insights from the CONCORDANCE registryBernadette Aliprandi-Costa, James Sockler, Leonard Kritharides, et al.
European Heart Journal|April 5, 2008
Management and 6-month outcomes in elderly and very elderly patients with high-risk non-ST-elevation acute coronary syndromes: The Global Registry of Acute Coronary EventsGerard Devlin, Joel M Gore, John Elliott, et al.
Heart, Lung & Circulation|April 10, 2010
Overview and determinants of cardiovascular disease in indigenous populationsLeonard Kritharides, Alex Brown, David Brieger, et al.
The Annals of Pharmacotherapy|November 27, 2019
Trends of Use and Outcomes Associated With Glycoprotein-IIb/IIIa Inhibitors in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary InterventionRochelle M Gellatly, Cia Connell, Christianne Tan, et al.
Pageof 37